{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:27:16Z","timestamp":1767374836620},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,16]]},"DOI":"10.7759\/cureus.29240","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T18:37:26Z","timestamp":1663353446000},"source":"Crossref","is-referenced-by-count":2,"title":["Li-Fraumeni Syndrome: A Rare Genetic Disorder"],"prefix":"10.7759","author":[{"given":"Faria","family":"Tazin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A","family":"Israr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Omoleye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vern","family":"Orlang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.4398","article-title":"Analysis of the Li-Fraumeni spectrum based on an international germline TP53 variant data set: an international agency for research on cancer TP53 database analysis","volume":"7","author":"Kratz CP","year":"2021","unstructured":"Kratz CP, Freycon C, Maxwell KN, et al.. Analysis of the Li-Fraumeni spectrum based on an international germline TP53 variant data set: an international agency for research on cancer TP53 database analysis. JAMA Oncol. 2021, 7:1800-5. 10.1001\/jamaoncol.2021.4398","journal-title":"JAMA Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911413466","article-title":"Li-fraumeni syndrome","volume":"2","author":"Malkin D","year":"2011","unstructured":"Malkin D. Li-fraumeni syndrome. Genes Cancer. 2011, 2:475-84. 10.1177\/1947601911413466","journal-title":"Genes Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab118","article-title":"Li-Fraumeni syndrome in the cancer genomics era","author":"Foulkes WD","year":"2021","unstructured":"Foulkes WD, Polak P. Li-Fraumeni syndrome in the cancer genomics era. J Natl Cancer Inst. 2021, 10.1093\/jnci\/djab118","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-020-00709-5","article-title":"Cancer surveillance for individuals with Li-Fraumeni syndrome","volume":"28","author":"Kratz CP","year":"2020","unstructured":"Kratz CP, Villani A, Nichols KE, Schiffman J, Malkin D. Cancer surveillance for individuals with Li-Fraumeni syndrome. Eur J Hum Genet. 2020, 28:1481-2. 10.1038\/s41431-020-00709-5","journal-title":"Eur J Hum Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.8.606","article-title":"Multiple primary cancers in families with Li-Fraumeni syndrome","volume":"90","author":"Hisada M","year":"1998","unstructured":"Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998, 90:606-11. 10.1093\/jnci\/90.8.606","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/348747a0","article-title":"Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome","volume":"348","author":"Srivastava S","year":"1990","unstructured":"Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990, 348:747-9. 10.1038\/348747a0","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin D","year":"1990","unstructured":"Malkin D, Li FP, Strong LC, et al.. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990, 250:1233-8. 10.1126\/science.1978757","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.16.4657","article-title":"Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation","volume":"17","author":"Venkatachalam S","year":"1998","unstructured":"Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D, Donehower LA. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 1998, 17:4657-67. 10.1093\/emboj\/17.16.4657","journal-title":"EMBO J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201041","article-title":"A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene","volume":"14","author":"Varley JM","year":"1997","unstructured":"Varley JM, Thorncroft M, McGown G, et al.. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Oncogene. 1997, 14:865-71. 10.1038\/sj.onc.1201041","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.14.6413","article-title":"Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein","volume":"89","author":"Frebourg T","year":"1992","unstructured":"Frebourg T, Kassel J, Lam KT, et al.. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. Proc Natl Acad Sci U S A. 1992, 89:6413-7. 10.1073\/pnas.89.14.6413","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1997)9:2<157::AID-HUMU8>3.0.CO;2-6","article-title":"Three germline mutations in the TP53 gene","volume":"9","author":"Cornelis RS","year":"1997","unstructured":"Cornelis RS, van Vliet M, van de Vijver MJ, et al.. Three germline mutations in the TP53 gene. Hum Mutat. 1997, 9:157-163. 10.1002\/(SICI)1098-1004(1997)9:2&lt;157::AID-HUMU8&gt;3.0.CO;2-6","journal-title":"Hum Mutat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8144","article-title":"Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia","volume":"29","author":"Hof J","year":"2011","unstructured":"Hof J, Krentz S, van Schewick C, et al.. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia. J Clin Oncol. 2011, 29:3185-93. 10.1200\/JCO.2011.34.8144","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2179","article-title":"Recommended guidelines for validation, quality control, and reporting of TP53 variants in clinical practice","volume":"77","author":"Leroy B","year":"2017","unstructured":"Leroy B, Ballinger ML, Baran-Marszak F, et al.. Recommended guidelines for validation, quality control, and reporting of TP53 variants in clinical practice. Cancer Res. 2017, 77:1250-60. 10.1158\/0008-5472.CAN-16-2179","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30249-2","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study","volume":"17","author":"Villani A","year":"2016","unstructured":"Villani A, Shore A, Wasserman JD, et al.. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol. 2016, 17:1295-1305. 10.1016\/S1470-2045(16)30249-2","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.9257","article-title":"American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers","volume":"32","author":"Lu KH","year":"2014","unstructured":"Lu KH, Wood ME, Daniels M, et al.. American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol. 2014, 32:833-40. 10.1200\/JCO.2013.50.9257","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.3711","article-title":"Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors","volume":"31","author":"Cust\u00f3dio G","year":"2013","unstructured":"Cust\u00f3dio G, Parise GA, Kiesel Filho N, et al.. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J Clin Oncol. 2013, 31:2619-26. 10.1200\/JCO.2012.46.3711","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.41","article-title":"Li-Fraumeni syndrome: cancer risk assessment and clinical management","volume":"11","author":"McBride KA","year":"2014","unstructured":"McBride KA, Ballinger ML, Killick E, et al.. Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nat Rev Clin Oncol. 2014, 11:260-71. 10.1038\/nrclinonc.2014.41","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115213-li-fraumeni-syndrome-a-rare-genetic-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:18Z","timestamp":1707507558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115213-li-fraumeni-syndrome-a-rare-genetic-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.29240","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}